Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1639-1642

  Schoenfeld, A ^a   Luqmani, Y ^b   Sinnett, H D ^a   Shousha, S ^b   Coombes, R C ^a,b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Breast cancer; Keratin 19; Micrometastases

Indexed keywords

KERATIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; SOUTHERN BLOTTING; TUMOR VOLUME;

EID: 0029961444     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.601     Document Type: Article

References (12)

1. BARTEK J, TAYLOR-PAPADIMITRIOU J, MILLER N AND MILLIS R. (1985). Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int. J. Cancer, 35, 299-306.
2. BLOOM HJG AND RICHARDSON WW. (1957). Histological grading and prognosis in breast cancer. Br. J. Cancer, 11, 359-364.
3. COOMBES RC, POWLES TJ, GAZET J-C, NASH AG, FORD HT, MCKINNA A AND NEVILLE AM. (1980). Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet, 1, 296-298.
4. DE KONING HJ, FRACHEBOUD J, BOER R, VERBEEK AL, COLLETTE HJ, HENDRIKS JH, INEVELD BM, BRUYN AE AND MAAS PJ. (1995). Nation-wide breast cancer screening in the Netherlands: support for breast cancer mortality reduction. National Evaluation Team for Breast Cancer Screening. Int. J. Cancer, 60, 777-780.
5. FISHER B, WOLMARK N, BAUER M, REDMOND C AND GEBHARDT M. (1981). The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg. Gynaecol. Obstet., 152, 765-772.
6. KRISMANN M, TODT B, SCHRODER J, GAREIS D, MULLER K-M, SIEGFRIED SEEBER AND SCHUTTE J. (1995). Low specificity of Cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol., 13, 2769-2775.
7. MANSI JL, EASTON D, BERGER U, GAZET J-C, FORD HT, DEARNALEY D AND COOMBES RC. (1991). Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur. J. Cancer, 27, 1552-1555.
8. NEVILLE AM. (1990). Are breast cancer micrometastases worth detecting? J. Pathol., 161, 283-284.
9. NOGUCHI S, AIHARA T, NAKAMORI S, MOTOMURA K, INAJI H, IMAOKO S AND KOYAMA H. (1994). The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer, 74, 1595-1600.
10. SCHOENFELD A, LUQMANI Y, SMITH D, O'REILLY S, SHOUSHA S, SINNETT HD AND COOMBES RC. (1994). Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res., 54, 2986-2990.
11. TRAWEEK ST, LIU J AND BATTIFORA H. (1993). Keratin Gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am. J. Pathol., 142, 1111-1118.
12. TROJANI M, DE MASCAREL I, BONICHON F, COINDRE JM AND DELSOL G. (1987). Micrometastases to axillary nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br. J. Cancer, 156, 303-306.